Colorectal Cancer Therapeutics Market | 2021 Global Industry Forecast To 2026, is latest report on Global Colorectal Cancer Therapeutics Industry, published by Fortune Business Insights. Report provides comprehensive information on Global Colorectal Cancer Therapeutics Market and Impact of Covid-19 on Healthcare Industry. According to report Global market value of Colorectal Cancer Therapeutics is to hit USD 16.58 billion value by 2026 at CAGR of 7.6%. Report segments Colorectal Cancer Therapeutics Market By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Others), By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026
Major Colorectal Cancer Therapeutics manufacturers are studied in this report for better understanding of global market scenario:
- Novartis AG
- Bayer AG
- Merck Sharp & Dohme Corp.
- Bristol Myers Squibb
- Pfizer Inc.
- Genentech, Inc.
- Ipsen Biopharmaceuticals, Inc.
- Regeneron Pharmaceuticals, Inc.
Get Sample Report Brochure Of Colorectal Cancer Therapeutics Market at:
The global colorectal cancer therapeutics market size is projected to reach USD 16.58 billion by 2026, owing to the rise in the prevalence of colorectal cancer worldwide. A report by Fortune Business Insights™ titled, “Colorectal Cancer Therapeutics Market Size, Share & Industry Analysis, By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Others), By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026,” provides a detailed analysis of the same.
According to the report, the colorectal cancer drugs market was valued at USD 9.26 billion in 2018. The forecast period is set from 2019 to 2026, and the market is likely to exhibit a CAGR of 7.6%. As per current colorectal cancer therapeutics market trends, the targeted therapy segment is dominating the market in terms of therapy. This is attributed to the presence of a large number of prominent targeted cancer therapies such as Stivarga, Erbitux, and Avastin.
Launch of Better Therapeutics for Colorectal Cancer to Aid in Expansion of Market
The rise in awareness about colorectal cancer is a major factor driving the colorectal cancer therapeutics market growth. Additionally, the increasing number of corresponding product launches for effective colorectal cancer treatment is further expected to help increase the overall market growth in the forecast period. Moreover, the advent of the latest initiatives aiming to provide effective care of colorectal cancer patients is more likely to aid in the expansion of the market for colorectal cancer drugs. Furthermore, the high mortality rates, coupled with the rising demand for effective cancer therapeutics worldwide, is prognosticated to have a positive effect on the colorectal cancer medications market size in the forthcoming years.
Speak to Colorectal Cancer Therapeutics Industry Analyst:
Competitive And Regional Analysis:
This report focuses on Colorectal Cancer Therapeutics Market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report.
Rise in Disposable Incomes and Increasing Awareness about Therapeutic Procedures to Help Asia Pacific Witness Rapid Growth
Geographically, North America is leading the market with a high prevalence of colorectal cancer. In 2018, North America earned USD 4.13 billion, owing to the new product launches in and around the region. Thus, the factors mentioned above are likely to help this region continue dominating the market in the future too.
On the other side, the continuously improving healthcare infrastructure, coupled with the rise in disposable incomes of people in Asia Pacific is expected to boost the regional market in the forecast period. Colorectal cancer is a major reason for the rise in mortality rates, coupled with the rising awareness about colorectal cancer therapeutics that will help this region attract high colorectal cancer therapeutics market revenue in the near future.
Colorectal Cancer Therapeutics Highlights of the Report:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the Supply Chain Analytics market.
- Product Development/Innovation: Detailed insights on the upcoming technologies, RandD activities, and product launches in the market
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Supply Chain Analytics market
Browse complete report information at:
Table of Content:
1 Colorectal Cancer Therapeutics Market Overview
1.1 Colorectal Cancer Therapeutics Product Overview
1.2 Colorectal Cancer Therapeutics Market Segment by Type
1.3 Global Colorectal Cancer Therapeutics Market Size by Type (2015-2026)
1.3.1 Colorectal Cancer Therapeutics Global Market Size Overview by Type (2015-2026)
1.3.2 Global Colorectal Cancer Therapeutics Historic Market Size Review by Type (2015-2021)
1.3.2.1 Colorectal Cancer Therapeutics Sales Global Market Share Breakdown by Type (2015-2026)
1.3.2.2 Colorectal Cancer Therapeutics Global Market Share Breakdown by Type (2015-2026)
1.3.2.3 Global Colorectal Cancer Therapeutics Average Selling Price (ASP) by Type (2015-2026)
1.3.3 Colorectal Cancer Therapeutics Market Size Forecast by Type (2021-2026)
1.3.3.1 Global Colorectal Cancer Therapeutics Sales Market Share Breakdown by Application (2021-2026)
1.3.3.2 Global Colorectal Cancer Therapeutics Revenue Market Share Breakdown by Application (2021-2026)
1.3.3.3 Global Colorectal Cancer Therapeutics Average Selling Price (ASP) by Application (2021-2026)
1.4 Key Regions Market Size Segment by Type (2015-2021)
1.4.1 North America Colorectal Cancer Therapeutics Sales Breakdown by Type (2015-2026)
1.4.2 Europe Colorectal Cancer Therapeutics Sales Breakdown by Type (2015-2026)
1.4.3 Asia-Pacific Colorectal Cancer Therapeutics Sales Breakdown by Type (2015-2026)
1.4.4 Latin America Colorectal Cancer Therapeutics Sales Breakdown by Type (2015-2026)
1.4.5 Middle East and Africa Colorectal Cancer Therapeutics Sales Breakdown by Type (2015-2026)
2 Global Colorectal Cancer Therapeutics Market Competition by Company
2.1 Global Top Players by Colorectal Cancer Therapeutics Sales (2015-2021)
2.2 Global Top Players by Colorectal Cancer Therapeutics Revenue (2015-2021)
2.3 Global Top Players Colorectal Cancer Therapeutics Average Selling Price (ASP) (2015-2021)
2.4 Global Top Company Colorectal Cancer Therapeutics Manufacturing Base Distribution, Sales Area, Product Type
2.5 Colorectal Cancer Therapeutics Market Competitive Situation and Trends
2.5.1 Colorectal Cancer Therapeutics Market Growth Rate (2015-2021)
2.5.2 Global 5 and 10 Largest Company by Colorectal Cancer Therapeutics Sales and Revenue in 2019
2.6 Global Colorectal Cancer Therapeutics Top Company by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colorectal Cancer Therapeutics as of 2019)
2.7 Date of Key Company Enter into Colorectal Cancer Therapeutics Market
2.8 Key Company Colorectal Cancer Therapeutics Product Offered
2.9 Mergers and Acquisitions, Expansion
3 Global Colorectal Cancer Therapeutics Status and Outlook by Region (2015-2026)
3.1 Global Colorectal Cancer Therapeutics Market Size and CAGR by Region: 2015 VS 2021 VS 2026
3.2 Global Colorectal Cancer Therapeutics Market Size Market Share by Region (2015-2021)
3.2.1 Global Colorectal Cancer Therapeutics Sales Market Share by Region (2015-2021)
3.2.2 Global Colorectal Cancer Therapeutics Revenue Market Share by Region (2015-2021)
3.2.3 Global Colorectal Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2015-2021)
3.3 Global Colorectal Cancer Therapeutics Market Size Market Share by Region (2021-2026)
3.3.1 Global Colorectal Cancer Therapeutics Sales Market Share by Region (2021-2026)
3.3.2 Global Colorectal Cancer Therapeutics Revenue Market Share by Region (2021-2026)
3.3.3 Global Colorectal Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
3.4 North America Colorectal Cancer Therapeutics Market Size By Growth (2015-2026)
3.4.1 North America Colorectal Cancer Therapeutics Revenue By Growth (2015-2026)
3.4.2 North America Colorectal Cancer Therapeutics Sales By Growth (2015-2026)
3.5 Asia-Pacific Colorectal Cancer Therapeutics Market Size By Growth (2015-2026)
3.5.1 Asia-Pacific Colorectal Cancer Therapeutics Revenue By Growth (2015-2026)
3.5.2 Asia-Pacific Colorectal Cancer Therapeutics Sales By Growth (2015-2026)
3.6 Europe Colorectal Cancer Therapeutics Market Size By Growth (2015-2026)
3.6.1 Europe Colorectal Cancer Therapeutics Revenue By Growth (2015-2026)
3.6.2 Europe Colorectal Cancer Therapeutics Sales By Growth (2015-2026)
3.7 Latin America Colorectal Cancer Therapeutics Market Size By Growth (2015-2026)
3.7.1 Latin America Colorectal Cancer Therapeutics Revenue By Growth (2015-2026)
3.7.2 Latin America Colorectal Cancer Therapeutics Sales By Growth (2015-2026)
3.8 Middle East and Africa Colorectal Cancer Therapeutics Market Size By Growth (2015-2026)
3.8.1 Middle East and Africa Colorectal Cancer Therapeutics Revenue By Growth (2015-2026)
3.8.2 Middle East and Africa Colorectal Cancer Therapeutics Sales By Growth (2015-2026)
4 Global Colorectal Cancer Therapeutics by Application
4.1 Colorectal Cancer Therapeutics Segment by Application
4.1.1 Residential
4.1.2 Commercial
4.2 Global Colorectal Cancer Therapeutics Sales by Application: 2015 VS 2021 VS 2026
4.3 Global Colorectal Cancer Therapeutics Historic Sales by Application (2015-2021)
4.4 Global Colorectal Cancer Therapeutics Forecasted Sales by Application (2021-2026)
4.5 Key Regions Colorectal Cancer Therapeutics Market Size by Application
4.5.1 North America Colorectal Cancer Therapeutics by Application
4.5.2 Europe Colorectal Cancer Therapeutics by Application
4.5.3 Asia-Pacific Colorectal Cancer Therapeutics by Application
4.5.4 Latin America Colorectal Cancer Therapeutics by Application
4.5.5 Middle East and Africa Colorectal Cancer Therapeutics by Application
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune -411045, Maharashtra, India.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245